By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
November 11, 2025 9:27 AM EST
Medical Herald
Search
  • Health Conditions
    Health ConditionsShow More
    Study Highlights Rising Heart Risks in Pregnant Women
    Pregnancy & Parenting
    ‘New Mom School’ Helps Women Through Postpartum Challenges
    Pregnancy & Parenting
    Beware of Counterfeit Weight Loss Drugs Sold Online
    Weight Management
    Father’s Back Pain Leads to Tragic Cancer Diagnosis
    Cancer
    Novo Nordisk’s CEO Emphasizes Strategic Risks to Lead Obesity Market
    Weight Management
  • Wellness & Self-Care
    Wellness & Self-CareShow More
    Introducing the Hormometer: Track Cortisol at Home
    Wellness & Self-Care
    First Responders Turn to Ketamine for Mental Health Relief
    Mental Health
    Enjoy Healthy Living This Fall with a Delicious Protein Shake
    Healthy Living
    Top 3 Bedtime Yoga Poses for Better Sleep
    Wellness & Self-Care
    Why Founders Often Fail to Embrace Their Own Culture
    Mental Health
  • Nutrition & Fitness
    Nutrition & FitnessShow More
    Fibermaxxing: The Rising Trend in Nutritional Focus
    Diet & Nutrition
    Gutzy Organic Launches Healthy Prebiotic Protein Smoothies
    Diet & Nutrition
    Achieve Your Nutrition Goals with Nourish and Insurance
    Nutrition & Fitness
    Delicious Roasted Salmon with Olives from Dan Pelosi
    Healthy Recipes
    Short Exercise Bursts: A New Trend in Fitness?
    Fitness
  • Innovation
    InnovationShow More
    Drug Tied to Fatal Crashes and Risks of Weight-Loss Pills
    Drugs & Medications
    GLP-1 Medications Like Ozempic May Affect Medical Scan Results
    Drugs & Medications
    Revolutionizing Men’s Health with Innovative Underwear
    Innovation
    Heart Monitors Aid Biologists in Saving Endangered Species
    Innovation
    AstraZeneca Launches $4.5B Virginia Manufacturing Facility
    Innovation
  • News
    NewsShow More
    Advances in Nigeria’s Real-Time NTD Treatment Reporting System
    News
    WIC Program Secures $300M Amid Government Shutdown Concerns
    News
    Guy Benson Shares Early Cancer Diagnosis and Encourages Skin Checks
    News Skin Care
    Congress Stalemate Threatens Health Insurance for Millions
    News
    Explorer Middle School Unveils New Gymnasium
    News
Font ResizerAa
Medical HeraldMedical Herald
  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
Search
  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
Follow US
Copyright © 2025, Medical Herald. All Rights Reserved.
Home » News » J&J Ordered to Pay $966 Million in Talc Baby Powder Case

J&J Ordered to Pay $966 Million in Talc Baby Powder Case

By Liam Fraser
Published: October 21, 2025
Share

In a landmark ruling, a California jury has mandated Johnson & Johnson (J&J) to compensate the family of Mae Moore a staggering $966 million. This comes after Moore, who passed away in 2021 at the age of 88, attributed her diagnosis of mesothelioma, a cancer linked to asbestos exposure, to her lifelong use of the company’s baby powder.

The verdict was reached late Monday by a jury in Los Angeles, making it the largest award for a single plaintiff in the ongoing 15-year litigation concerning J&J’s talc products. The jury awarded Moore’s family $16 million in compensatory damages, accompanied by an unprecedented $950 million in punitive damages. This decision underscores the jury’s judgment against the company, which was accused of concealing the health risks associated with its beloved powder.

In reaction to the verdict, Erik Haas, Worldwide Vice President of Litigation at J&J, expressed the company’s intention to appeal, labeling the verdict as “egregious and unconstitutional.” He further emphasized that it contradicts the outcomes of the vast majority of previous talc-related cases where J&J has secured favorable results.

This verdict emerges at a critical time for J&J, as the company is preparing for a series of jury trials related to its talc-based baby powder. Notably, the product was removed from the global market in 2023 following mounting legal challenges. J&J has made multiple unsuccessful attempts to leverage bankruptcy courts in an effort to negotiate settlements for the thousands of claims against it.

Jessica Dean, a Texas attorney representing Moore’s family, highlighted the lengthy journey to justice, stating, “It took this family five years to get their day in court and we’re pleased the jury concluded J&J should be held accountable.”

Despite J&J having spent over $3 billion in settling lawsuits that alleged its baby powder contained harmful asbestos, the company still faces more than 70,000 claims linking the product to mesothelioma and ovarian cancers. Many of these cases have been grouped together in New Jersey under a federal judge for pre-trial proceedings.

Historically, juries have found J&J and its spinoff, Kenvue, liable for cancer cases related to their baby powder, awarding billions in damages. However, several of these financial awards have been reduced or overturned through appeals.

J&J has consistently maintained that its talc products are safe and devoid of asbestos, asserting that the powder has been marketed responsibly for over a century. Nonetheless, court documents presented by plaintiffs suggest internal J&J communications indicated the company may have been aware of potential asbestos presence in its talc products since the early 1970s.

The 2018 case against J&J, which resulted in a $4.7 billion jury award to 20 women in Missouri, stands as the largest verdict against the company to date. That award was later reduced to $2.1 billion on appeal, with J&J ultimately paying around $2.5 billion with interest.

Experts believe that Moore’s award should also expect a reduction. According to Bloomberg Intelligence analyst Holly Froum, U.S. Supreme Court guidelines stipulate that punitive damages should not exceed ten times the compensatory damages to be deemed reasonable.

Court filings indicate that Moore used J&J’s baby powder and the Shower-to-Shower powder variant for approximately 80 years. The jury concluded that J&J had deliberately failed to inform users like Moore about the cancer risks associated with its products. It is worth noting that J&J sold Shower-to-Shower to Valeant Pharmaceuticals for around $150 million in 2012.

The case is officially recorded as Moore v. J&J, JCCP 4674, 21STCV055134, in the California Superior Court (Los Angeles).Diseases & Conditions

Share This Article
Facebook LinkedIn Email Copy Link
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

HOT NEWS

Advances in Nigeria’s Real-Time NTD Treatment Reporting System

November 10, 2025

WIC Program Secures $300M Amid Government Shutdown Concerns

A $300M boost from the Trump administration ensures WIC continues supporting 6 million women and…

November 10, 2025

Drug Tied to Fatal Crashes and Risks of Weight-Loss Pills

Drug-related crashes and unsafe weight-loss pills are fueling a public health crisis, prompting experts to…

November 10, 2025

Introducing the Hormometer: Track Cortisol at Home

Eli Health’s Hormometer offers at-home cortisol tracking via saliva and smartphone, giving users fast, AI-driven…

November 10, 2025

YOU MAY ALSO LIKE

Yale New Haven Settles for $45M in Hospital Purchase Dispute

Yale New Haven settles for $45M with Prospect Medical over failed CT hospital deal, as Hartford HealthCare and UConn eye…

October 1, 2025

Man with Mental Health Issues Vandalizes Washington Capitol

A suspect in mental crisis vandalized the Washington state Capitol, causing major damage and reigniting calls for stronger mental health…

October 9, 2025

MPR News Host Angela Davis Announces Leave for Cancer Treatment

Angela Davis of MPR News takes time off for cancer treatment, sharing gratitude and optimism as she faces this challenge…

October 16, 2025

Union County Launches Free Gardening Helpline for Residents

Union County’s free gardening helpline connects residents with Rutgers-trained Master Gardeners for expert advice on soil, pests, planting, and more.

October 1, 2025

Medical Herald is your trusted source for medical news, scientific research, health policy updates, and expert insights from around the world. 

Category

  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
  • Privacy Policy
  • About Us
  • Contact

Follow US: 

  • Grow Big Agency Sites:
  • London Business Journal
Copyright © 2025, Medical Herald. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?